Comparison of Platelet-Rich Plasma and Prolotherapy for Plantar Fasciitis

This randomized controlled trial evaluates the comparative effectiveness of platelet-rich plasma (PRP) therapy and prolotherapy in patients with plantar fasciitis. Both interventions are commonly used regenerative injection therapies intended to improve pain and functional outcomes in patients who do not respond adequately to conventional conservative treatments. Participants diagnosed with plantar fasciitis will be randomly assigned to receive either PRP injection or prolotherapy. The results of this study aim to identify the more effective injection therapy for improving clinical outcomes in patients with plantar fasciitis

NCT Number	NCT07480967
Lead Sponsor	Bangladesh Medical University
Conditions	Planter Fasciitis
Enrollment	68 participants
Start Date	2026-04-01
Primary Completion	2026-08-31 (estimated)
Study Completion	2027-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-03-20